−32.2
Rani Therapeutics Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−46.5
FY23:
−51.2
FY24:
−35.5
FY25:
−18.7
Change from FY21 to FY25
millions USD
FY21:
−0.51
FY22:
−72.4
FY23:
29.9
FY24:
19.8
FY25:
−7.03
Change from FY21 to FY25
millions USD
FY21:
77.1
FY22:
29.0
FY23:
0.23
FY24:
13.6
FY25:
40.3
millions USD
FY21:
44.4
FY22:
−89.9
FY23:
−21.1
FY24:
−2.10
FY25:
14.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.8
FY22:
−48.1
FY23:
−52.5
FY24:
−35.8
FY25:
−18.8
All amounts in millions USD